Ikarian Capital, LLC - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 189 filers reported holding KRYSTAL BIOTECH INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$9,802,000
+710.6%
845
-91.8%
1.18%
+510.9%
Q2 2023$1,209,220
+46.6%
10,3000.0%0.19%
+3.2%
Q1 2023$824,618
-93.7%
10,300
-93.8%
0.19%
-94.1%
Q4 2022$13,142,598
+98.1%
165,900
+74.3%
3.17%
+139.9%
Q3 2022$6,635,000
-77.9%
95,200
-83.4%
1.32%
-37.4%
Q3 2021$30,012,000574,8002.11%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q3 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 1,913,280$153,177,1976.65%
Frazier Life Sciences Management, L.P. 945,407$75,689,2845.48%
S Squared Technology, LLC 108,215$8,663,6935.14%
Nicholas Investment Partners, LP 374,718$29,999,9232.28%
Avoro Capital Advisors LLC 1,750,000$140,105,0002.08%
Artal Group S.A. 412,082$32,9911.96%
First Light Asset Management, LLC 195,980$15,690,1591.41%
Integral Health Asset Management, LLC 85,000$6,805,1001.37%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 61,000$4,883,6601.36%
Hood River Capital Management LLC 447,393$35,818,0001.16%
View complete list of KRYSTAL BIOTECH INC shareholders